Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
11/15/1995 | CN1111507A Controlled release oxybutynin formulations |
11/15/1995 | CN1111506A Formulations containing carotenoids and procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals |
11/15/1995 | CN1111505A Medicine membrane for curing stomatocace |
11/14/1995 | US5466849 Siloxane derivatives, producing method thereof and agents including siloxane derivative |
11/14/1995 | US5466681 Receptor conjugates for targeting penicillin antibiotics to bacteria |
11/14/1995 | US5466587 Method for introducing a biological substance into a target |
11/14/1995 | US5466461 Polysaccharide esters |
11/14/1995 | US5466451 Carbon dioxide, supercritical |
11/14/1995 | US5466446 Topical compositions containing bensoyl peroxide and clindamycin and method of use thereof |
11/14/1995 | CA2149282A1 Gemfibrozil containing pharmaceutical compositions |
11/10/1995 | CA2147390A1 Process for the production of a concentrate of polyunsaturated fatty acid esters |
11/09/1995 | WO1995030020A1 Novel nucleic acid/polymer complexes, method for preparing same and use thereof for cell transfection |
11/09/1995 | WO1995029923A1 Process for the preparation of mono- and bis(phosphocholine) derivatives which have antifungal activity |
11/09/1995 | WO1995029916A1 Electron-deficient porphyrins and processes and intermediates for preparing same |
11/09/1995 | WO1995029915A1 Polyethylene glycol derivatised dihydro or tetrahydro porphyrins, their preparation and their use as tumour localising, photosensitising compounds |
11/09/1995 | WO1995029704A1 Cell lines obtained by in vivo migration and by fusion with autoimmune cells |
11/09/1995 | WO1995029702A1 Texaphyrin solid-supports and devices |
11/09/1995 | WO1995029701A1 Vaccines for oral immunization against infecting agents |
11/09/1995 | WO1995029683A1 Pharmaceutical composition comprising hyaluronic acid for the clearing of arteriosclerosis |
11/09/1995 | WO1995029678A1 Pharmaceutical composition for transdermal delivery |
11/09/1995 | WO1995029677A1 Lactone stable formulation of camptothecin or 7-ethyl camptothecin |
11/09/1995 | WO1995029673A1 Methods for modulating t cell responses by manipulating intracellular signal transduction |
11/09/1995 | WO1995029665A1 Effective dosage form for antiepileptic drugs |
11/09/1995 | WO1995029664A1 Modulated release from biocompatible polymers |
11/09/1995 | CA2575042A1 Effective dosage form for antiepileptic drugs |
11/09/1995 | CA2189469A1 Vaccines for oral immunization against infecting agents |
11/09/1995 | CA2189435A1 Polyethylene glycol derivatised dihydro or tetrahydro porphyrins, their preparation and their use as tumour localising, photosensitising compounds |
11/09/1995 | CA2187949A1 Electron-deficient porphyrins and processes and intermediates for preparing same |
11/08/1995 | EP0680990A1 Collagen-synthetic polymer matrices prepared using a multiple step reaction |
11/08/1995 | EP0680989A1 Crystal ferromagnetic compounds from naphtylamine and amino aromatic compounds copolymer derivatives |
11/08/1995 | EP0680975A1 Acylated gamma-cyclodextrins |
11/08/1995 | EP0680759A1 Transdermal delivery of calcium channel blockers, such as nifedipine |
11/08/1995 | EP0680754A2 Percutaneous absorption preparation containing Buprenorphine |
11/08/1995 | EP0680752A2 Conditioned water soluble substances |
11/08/1995 | EP0680751A1 Lipid vesicles |
11/08/1995 | EP0680748A1 Cosmetic and/or dermatological composition containing a cationic polymeric gelling agent and its uses especially for skin depigmentation |
11/08/1995 | EP0680495A1 Structured copolymers used as absorbents, gels and carriers of metal ions |
11/08/1995 | EP0680340A1 Amplified direction of effector groups to specific target cells in an animal |
11/08/1995 | EP0680338A1 Ganglioside-klh conjugate vaccines with qs-21 |
11/08/1995 | EP0680335A1 Sequential targeting of tumor sites with oligonucleotide conjugates of antibody and complementary oligonucleotide conjugates of chelated radionuclide |
11/08/1995 | EP0680320A1 Stable oral ci-981 formulation and process of preparing same |
11/08/1995 | EP0615439B1 Slow-release ibuprofen-containing medicament and its use |
11/08/1995 | EP0572486B1 Delayed release oral dosage forms for treatment of intestinal disorders |
11/08/1995 | EP0548096B1 Amphiphilic fluorine derivatives with telomeric structures; preparation and biomedical applications |
11/08/1995 | EP0512109B1 Oral pharmaceutical composition containing cyclosporin and process for preparing same |
11/08/1995 | EP0434765B1 Targeting substance-diagnostic/therapeutic agent conjugates having schiff base linkages |
11/08/1995 | CN1111445A Pharmaceutical emulsions containing bioactive steroids |
11/08/1995 | CN1111130A Stable lyophilized thiotepa composition |
11/08/1995 | CN1111128A Topical anti-inflammatory compositions containing piroxican |
11/07/1995 | US5464932 Photocrosslinkable polyphosphazenes and their use as microencapsulation materials |
11/07/1995 | US5464815 Extending plasma half-life of selectin by coadministering with compound which inhibits binding of selectin to low affinity heparin-like site on surface of cells of organ perfused with blood; assaying sensitivity; pharmaceutical composition |
11/07/1995 | US5464634 Red blood cell surrogate |
11/07/1995 | US5464629 Method of forming hydrogel particles having a controlled size using liposomes |
11/07/1995 | US5464614 Stabilized superoxide dismutase (SOD) composition |
11/07/1995 | US5464612 Solid preparation comprising ion exchanger and active agent |
11/07/1995 | US5464013 Medical scanning and treatment system and method |
11/07/1995 | CA2148764A1 Copolymer ferromagnetic crystalline compounds derived from naphthylamine and aminoaromatic compounds |
11/07/1995 | CA2147918A1 Percutaneous absorption preparation |
11/07/1995 | CA2060048C Skin cream preparation for external use |
11/07/1995 | CA1337516C Polylactide compositions |
11/03/1995 | CA2143923A1 Collagen-synthetic polymer matrices prepared using a multiple step reaction |
11/02/1995 | WO1995029256A1 Chondroitinases i and ii, methods of preparation, and use thereof |
11/02/1995 | WO1995029186A1 Compositions and methods for cell transformation |
11/02/1995 | WO1995029178A1 Method for stabilizing compound dx-52-1 and lyophilized composition thereof |
11/02/1995 | WO1995029172A1 N-morpholino-n-nitrosaminoacetonitril cyclodextrin inclusion complexes |
11/02/1995 | WO1995028967A1 Contrast agents |
11/02/1995 | WO1995028966A1 Dendrimeric compounds |
11/02/1995 | WO1995028965A1 High solubility multicomponent inclusion complexes consisting of an acidic drug, a cyclodextrin and a base |
11/02/1995 | WO1995028964A1 Collagen preparation for the controlled release of active substances |
11/02/1995 | WO1995028963A1 Colon-specific drug release system |
11/02/1995 | WO1995028954A1 Formulations for factor ix |
11/02/1995 | WO1995028951A1 Formulations for il-11 |
11/02/1995 | WO1995028932A1 Transdermal delivery of alpha adrenoceptor blocking agents |
11/02/1995 | WO1995028930A1 Dosage forms and method for ameliorating male erectile dysfunction |
11/02/1995 | WO1995028927A1 Polymer coated tablet comprising amoxycillin and clavulanate |
11/02/1995 | WO1995028923A1 Taxane class derivative based pharmaceutical compositions |
11/02/1995 | WO1995028920A1 Acids and acid salts and their use in delivery systems |
11/02/1995 | WO1995028918A1 A ranitidine tablet having a hydroxypropylmethylcellulose containing coating and a method for producing said coating |
11/02/1995 | WO1995028917A1 Once-a-day metoprolol oral dosage form |
11/02/1995 | WO1995028916A1 Sustained release excipient |
11/02/1995 | WO1995028915A1 Red blood cell surrogate |
11/02/1995 | WO1995028914A1 Percutaneously administrable base composition and percutaneously administrable drug composition prepared therefrom |
11/02/1995 | WO1995028849A1 Non-separable starch-oil compositions |
11/02/1995 | WO1995028838A1 Modified amino acids for drug delivery |
11/02/1995 | EP0679628A1 Polyene derivatives, pharmaceutical and cosmetic composition containing them and their use |
11/02/1995 | EP0679401A1 Composition for curing lesioned tissue, process for producing the same, and use thereof |
11/02/1995 | EP0679400A1 Oral dosage forms of azithromycin avoiding drugfood interaction |
11/02/1995 | EP0679398A1 Immunopotentiating and infection protective agent and production thereof |
11/02/1995 | EP0679395A1 Pharmaceutical compositions containing a ketoprofen solution in a soft gelatine capsule and method to produce them |
11/02/1995 | EP0679391A2 Solid pharmaceutical dosage form containing flavored film coating |
11/02/1995 | EP0679388A1 Cosmetic and/or dermatologic skin depigmentation composition and its use |
11/02/1995 | EP0679339A1 Processing aid for making shearform matrix |
11/02/1995 | EP0679163A1 Growth differentiation factor-3 |
11/02/1995 | EP0679095A1 Modified insulin-like growth factors |
11/02/1995 | EP0679094A1 Compounds for targeting |
11/02/1995 | EP0679083A1 Prevention and treatment of sepsis |
11/02/1995 | EP0679079A1 Solution containing igf-1 |
11/02/1995 | CA2188682A1 Method for stabilizing compound dx-52-1 and lyophilized composition thereof |
11/02/1995 | CA2188496A1 Polymer coated tablet comprising amoxycillin and clavulanate |
11/02/1995 | CA2188467A1 Modified amino acids for drug delivery |